My Companies
Notification
Account
Log Out
Login
RPG Life Sciences to transfer API business to subsidiary RPG Active Pharma; InvAscent to invest up to INR 243 cr, and RPG Active Pharma to acquire Actis Generics, marking its first acquisition.
RPG Life Sciences Approves ₹243 Crore API Subsidiary Investment And Acquisition
RPG Life Sciences Approves Rs 243 Crore Investment, Actis Generics Acquisition
RPG Life Sciences Board Approves ₹243 Crore Investment And Actis Generics Acquisition